Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male SEA Japanese quail and rats
- 1 September 1985
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 56 (3) , 313-321
- https://doi.org/10.1016/0021-9150(85)90006-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Activity of ethyl 5-(p-chlorophenoxy)-3-hydroxy-3-methyl-pentanoate, a new hypocholesterolemic compound, in male rats and sea japanese quailAtherosclerosis, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- ANIMAL-MODELS FOR AN INTEGRATED APPROACH TO THE PHARMACOLOGIC CONTROL OF ATHEROSCLEROSIS1979
- Cholesterol in the Prediction of Atherosclerotic DiseaseAnnals of Internal Medicine, 1979
- Plasma high-density lipoprotein cholesterol level. Influence of risk factor interventionJAMA, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- MANAGEMENT OF KHELLIN TOXICITYThe Lancet Healthy Longevity, 1952
- THE TREATMENT OF ANGINA PECTORIS WITH KHELLINAnnals of Internal Medicine, 1952
- A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITYJournal of Biological Chemistry, 1952
- The coronary vasodilator action of khellinAmerican Heart Journal, 1949